Guaifenesin,dextromethorphan Hbr Capsule, Liquid Filled
NDC Package 35916-0759-2
Package Information
Guaifenesin, Dextromethorphan Hbr capsules is usestemporarily relieves cough due to minor throat and bronchial irritation as may occur with a coldhelps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Softgel Healthcare Pvt Ltd, this product is identified by NDC 35916-0759 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1661740 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG Oral Capsule
- RxCUI: 1661740 - dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Oral Capsule
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 35916 - Softgel Healthcare Pvt Ltd
- 35916-0759 - Guaifenesin, Dextromethorphan Hbr
- 35916-0759-2 - 2 POUCH in 1 BOX / 3000 CAPSULE, LIQUID FILLED in 1 POUCH
- 35916-0759 - Guaifenesin, Dextromethorphan Hbr
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (35916-0759). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 35916-0759-2 identifies a specific commercial package of 2 pouch in 1 box / 3000 capsule, liquid filled in 1 pouch of Guaifenesin, Dextromethorphan Hbr, a human over the counter drug labeled by Softgel Healthcare Pvt Ltd. This capsule, liquid filled is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Softgel Healthcare Pvt Ltd on July 11, 2025. The current certification is valid through December 31, 2026.
How is this Softgel Healthcare Pvt Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 35916075902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.